Atlas Trials

A Comparative Study of New Formulation and Approved Formulation for Levothyroxine in Healthy Volunteers

Clinical trial NCT03979274 · COMPLETED

Trial details

NCT number
NCT03979274
Sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2019-12-06
Primary completion
2020-01-13
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.